Community Healthcare Analyst Ratings
Community Healthcare Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/22/2023 | 7.04% | Baird | $43 → $33 | Downgrades | Outperform → Neutral |
| 07/06/2023 | — | Colliers Securities | Upgrades | Neutral → Buy | |
| 02/16/2023 | 39.47% | Baird | $38 → $43 | Maintains | Outperform |
| 01/17/2023 | 55.69% | Truist Securities | $43 → $48 | Maintains | Buy |
| 01/17/2023 | 45.96% | Piper Sandler | $41 → $45 | Maintains | Overweight |
| 01/13/2023 | 42.72% | Janney Montgomery Scott | → $44 | Upgrades | Neutral → Buy |
| 10/07/2022 | 32.99% | Piper Sandler | $45 → $41 | Maintains | Overweight |
| 09/27/2022 | 39.47% | Evercore ISI Group | $45 → $43 | Maintains | Outperform |
| 07/11/2022 | 42.72% | Truist Securities | $49 → $44 | Maintains | Buy |
| 11/25/2020 | — | Evercore ISI Group | Upgrades | In-Line → Outperform | |
| 08/06/2020 | 78.4% | Piper Sandler | $38 → $55 | Maintains | Overweight |
| 06/08/2020 | 39.47% | Evercore ISI Group | → $43 | Downgrades | Outperform → In-Line |
| 05/14/2020 | 23.26% | Piper Sandler | $35 → $38 | Maintains | Overweight |
| 05/07/2020 | 29.74% | B. Riley Securities | → $40 | Downgrades | Buy → Neutral |
| 04/23/2020 | 26.5% | SunTrust Robinson Humphrey | $46 → $39 | Maintains | Buy |
| 03/20/2020 | 29.74% | B. Riley Securities | $47 → $40 | Upgrades | Neutral → Buy |
| 03/06/2020 | 52.45% | B. Riley Securities | $42 → $47 | Maintains | Neutral |
| 02/28/2020 | 68.67% | Baird | $48 → $52 | Maintains | Outperform |
| 11/18/2019 | — | Piper Sandler | Upgrades | Hold → Buy | |
| 11/07/2019 | 36.23% | B. Riley Securities | $38 → $42 | Maintains | Neutral |
| 07/10/2019 | — | Janney Montgomery Scott | Downgrades | Buy → Neutral | |
| 04/23/2019 | — | Berenberg | Initiates Coverage On | → Buy | |
| 04/10/2019 | 29.74% | Baird | → $40 | Initiates Coverage On | → Outperform |
| 03/28/2019 | 23.26% | DA Davidson | → $38 | Initiates Coverage On | → Neutral |
| 11/16/2018 | -93.51% | UBS | → $2 | Initiates Coverage On | → Sell |
| 11/12/2018 | 0.55% | B. Riley Securities | $32 → $31 | Maintains | Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/22/2023 | 7.04% | 貝爾德 | $43→$33 | 評級下調 | 跑贏→中性 |
| 07/06/2023 | - | 高力證券 | 升級 | 中性→購買 | |
| 02/16/2023 | 39.47% | 貝爾德 | $38→$43 | 維護 | 跑贏大盤 |
| 01/17/2023 | 55.69% | Truist證券 | $43→$48 | 維護 | 買 |
| 01/17/2023 | 45.96% | 派珀·桑德勒 | $41→$45 | 維護 | 超重 |
| 2023年1月13日 | 42.72% | 詹尼·蒙哥馬利·斯科特 | →$44 | 升級 | 中性→購買 |
| 10/07/2022 | 32.99% | 派珀·桑德勒 | $45→$41 | 維護 | 超重 |
| 09/27/2022 | 39.47% | Evercore ISI集團 | $45→$43 | 維護 | 跑贏大盤 |
| 07/11/2022 | 42.72% | Truist證券 | $49→$44 | 維護 | 買 |
| 11/25/2020 | - | Evercore ISI集團 | 升級 | 線內→表現優異 | |
| 08/06/2020 | 78.4% | 派珀·桑德勒 | $38→$55 | 維護 | 超重 |
| 06/08/2020 | 39.47% | Evercore ISI集團 | →$43 | 評級下調 | 勝過→同線 |
| 2020/05/14 | 23.26% | 派珀·桑德勒 | $35→$38 | 維護 | 超重 |
| 05/07/2020 | 29.74% | B.萊利證券 | →$40 | 評級下調 | 購買→中性 |
| 04/23/2020 | 26.5% | SunTrust Robinson Humphrey | $46→$39 | 維護 | 買 |
| 03/20/2020 | 29.74% | B.萊利證券 | $47→$40 | 升級 | 中性→購買 |
| 03/06/2020 | 52.45% | B.萊利證券 | $42→$47 | 維護 | 中性 |
| 02/28/2020 | 68.67% | 貝爾德 | $48→$52 | 維護 | 跑贏大盤 |
| 2019年11月18日 | - | 派珀·桑德勒 | 升級 | 持有→購買 | |
| 2019/07/11 | 36.23% | B.萊利證券 | $38→$42 | 維護 | 中性 |
| 2019年07月10日 | - | 詹尼·蒙哥馬利·斯科特 | 評級下調 | 購買→中性 | |
| 2019年04月23日 | - | 貝倫伯格 | 開始承保 | →購買 | |
| 2019年04月10日 | 29.74% | 貝爾德 | →$40 | 開始承保 | →跑贏大盤 |
| 2019/03/28 | 23.26% | 達·戴維森 | →$38 | 開始承保 | →中性 |
| 2018年11月16日 | -93.51% | 瑞銀集團 | →$2 | 開始承保 | →銷售 |
| 2018年11月12日 | 0.55% | B.萊利證券 | $32→$31 | 維護 | 中性 |
What is the target price for Community Healthcare (CHCT)?
社區醫療(CHCT)的目標價格是多少？
The latest price target for Community Healthcare (NYSE: CHCT) was reported by Baird on September 22, 2023. The analyst firm set a price target for $33.00 expecting CHCT to rise to within 12 months (a possible 7.04% upside). 8 analyst firms have reported ratings in the last year.
Baird於2023年9月22日報道了社區醫療保健(NYSE：CHCT)的最新目標價。這家分析公司將目標價定為33.00美元，預計CHCT將在12個月內升至(可能上漲7.04%)。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for Community Healthcare (CHCT)?
社區醫療(CHCT)的最新分析師評級是多少？
The latest analyst rating for Community Healthcare (NYSE: CHCT) was provided by Baird, and Community Healthcare downgraded their neutral rating.
Baird提供了對社區醫療(紐約證券交易所代碼：CHCT)的最新分析師評級，社區醫療下調了其中性評級。
When is the next analyst rating going to be posted or updated for Community Healthcare (CHCT)?
社區醫療(CHCT)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Community Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Community Healthcare was filed on September 22, 2023 so you should expect the next rating to be made available sometime around September 22, 2024.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閱公共財務報表，與社區醫療保健的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。社區衛生保健的上一次評級是在2023年9月22日提交的，所以你應該預計下一次評級將在2024年9月22日左右的某個時候提供。
Is the Analyst Rating Community Healthcare (CHCT) correct?
分析師對社區醫療保健(CHCT)的評級正確嗎？
While ratings are subjective and will change, the latest Community Healthcare (CHCT) rating was a downgraded with a price target of $43.00 to $33.00. The current price Community Healthcare (CHCT) is trading at is $30.83, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的社區醫療保健(CHCT)評級被下調，目標價為43.00美元至33.00美元。目前社區醫療保健(CHCT)的交易價格為30.83美元，超出了分析師的預測範圍。